Citation: Shuai Guo, Bei Liu, Mengjie Zhang, Chunhui Li, Xiaoxia Wang, Yuhua Weng, Lele Li, Yuanyu Huang. A novel polyethyleneimine-decorated FeOOH nanoparticle for efficient siRNA delivery[J]. Chinese Chemical Letters, ;2021, 32(1): 102-106. doi: 10.1016/j.cclet.2020.11.024 shu

A novel polyethyleneimine-decorated FeOOH nanoparticle for efficient siRNA delivery

Shuai Guo ^a ,
Bei Liu ^b ,
Mengjie Zhang ^a ,
Chunhui Li ^a ,
Xiaoxia Wang ^f ,
Yuhua Weng ^{a, e} ,
Lele Li ^{b, d} ,
Yuanyu Huang ^{a, c, *,}

a.
School of Life Science, Advanced Research Institute of Multidisciplinary Science, Key Laboratory of Molecular Medicine and Biotherapy, Institute of Engineering Medicine, Beijing Institute of Technology, Beijing 100081, China
b.
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology (NCNST), Beijing 100190, China
c.
School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China
d.
College of Materials Science and Optoelectronic Technology, University of Chinese Academy of Sciences, Beijing 100049, China
e.
Hunan University of Science and Engineering, Yongzhou 425199, China
f.
Institute of Molecular Medicine, Peking University, Beijing 100871, China

yyhuang@bit.edu.cn

yyhuang@pku.edu.cn

Received Date: 21 August 2020
Revised Date: 9 November 2020
Accepted Date: 11 November 2020
Available Online: 20 November 2020

Figures(5)

Despite the promising prospect of small interfering RNA (siRNA) for the treatment of diverse diseases, it remains challenging to develop novel delivery materials to desired tissues and cells. In this study, a novel iron oxyhydroxide (FeOOH) nanoparticle (NP) whose surface was modified with branched polyether-imide (PEI) was developed to deliver siRNA into the cancer cells. It was demonstrated that PEI-FeOOH (PFeOOH) efficiently complexed siRNA, mediated effective cellular uptake and endosomal escape, thereby triggering robust gene silencing in vitro. In addition, PFeOOH/siRNA formulation loading with anti-RRM2 siRNA effectively inhibited the growth of tumor tissues, and exhibited excellent safety profiles in vivo. Therefore, this study conceptually provided a FeOOH-based nucleic acid delivery vesicle which can potentially use to achieve diagnosis and therapy simultaneously.
- FeOOH,
- siRNA delivery,
- RRM2,
- RNA interference,
- Polyetherimide,
- Cancer treatment
1. [1]
  Y. Weng, H. Xiao, J. Zhang, et al., Biotechnol. Adv. 37 (2019) 801-825. doi: 10.1016/j.biotechadv.2019.04.012
2. [2]
  Y.Y. Huang, Prog. Biochem. Biophys. 46 (2019) 313-322.
3. [3]
  B. Hu, Y. Weng, X.H. Xia, et al., J. Gene Med. 21 (2019) e3097.
4. [4]
  J. Beloor, N. Maes, I. Ullah, et al., Cell Host Microbe 23 (2018) 549-556. doi: 10.1016/j.chom.2018.03.001
5. [5]
  Y. Yang, T. Liu, D. Shen, et al., PLoS Pathog. 15 (2019) e1007534. doi: 10.1371/journal.ppat.1007534
6. [6]
  M. Jimenez-Sanchez, W. Lam, M. Hannus, et al., Nat. Chem. Biol. 11 (2015) 347-354. doi: 10.1038/nchembio.1790
7. [7]
  P.J. Schmidt, I. Toudjarska, A.K. Sendamarai, et al., Blood 121 (2013) 1200-1208. doi: 10.1182/blood-2012-09-453977
8. [8]
  V. Veschi, Z. Liu, T.C. Voss, et al., Cancer Cell 31 (2017) 50-63. doi: 10.1016/j.ccell.2016.12.002
9. [9]
  S. Wang, X. Liu, S. Chen, et al., ACS Nano 13 (2019) 274-283. doi: 10.1021/acsnano.8b05639
10. [10]
  C. Xu, D. Li, Z. Cao, et al., Nano Lett. 19 (2019) 2688-2693. doi: 10.1021/acs.nanolett.9b00657
11. [11]
  Y. Huang, Mol. Ther. Nucleic Acids 6 (2017) 116-132. doi: 10.1016/j.omtn.2016.12.003
12. [12]
  B. Hu, L. Zhong, Y. Weng, et al., Signal Transduct. Target. Ther. 5 (2020), doi:http://dx.doi.org/10.1038/s41392-020-0207-x.
13. [13]
  Y. Chen, B. Li, X. Chen, et al., Chin. Chem. Lett. 31 (2020) 1153-1158. doi: 10.1016/j.cclet.2019.06.022
14. [14]
  H. Gao, H. Feng, Y. Bai, et al., J. Biomed. Nanotechnol. 15 (2019) 1764-1770. doi: 10.1166/jbn.2019.2805
15. [15]
  M. Kim, G. Kim, D.W. Hwang, et al., J. Biomed. Nanotechnol. 15 (2019) 2401-2412. doi: 10.1166/jbn.2019.2866
16. [16]
  Y. Wang, F. Gao, X. Jiang, et al., J. Biomed. Nanotechnol. 15 (2019) 966-978. doi: 10.1166/jbn.2019.2762
17. [17]
  Z.L. Yu, J.X. Ye, X. Pei, et al., Acta Pharm. Sin. B 8 (2018) 116-126. doi: 10.1016/j.apsb.2017.11.011
18. [18]
  S. Guo, Y. Huang, Q. Jiang, et al., ACS Nano 4 (2010) 5505-5511. doi: 10.1021/nn101638u
19. [19]
  X. Liu, M. Liu, J. Chen, et al., Chin. Chem. Lett. 29 (2018) 1321-1332. doi: 10.1016/j.cclet.2018.03.004
20. [20]
  J.H. Lee, K. Lee, S.H. Moon, et al., Angew. Chem. Int. Ed. 48 (2009) 4174-4179. doi: 10.1002/anie.200805998
21. [21]
  B.L. Liu, H.C. Zhang, Y. Ding, Chin. Chem. Lett. 29 (2018) 1725-1730. doi: 10.1016/j.cclet.2018.12.006
22. [22]
  E.G. Liu, M. Zhang, H. Cui, et al., Acta Pharm. Sin. B 8 (2018) 956-968. doi: 10.1016/j.apsb.2018.07.012
23. [23]
  J.F. Qu, T.H. Che, L.B. Shi, et al., Chin. Chem. Lett. 30 (2019) 1198-1203. doi: 10.1016/j.cclet.2019.01.021
24. [24]
  Z. Abbasi, S. Rezayati, M. Bagheri, et al., Chin. Chem. Lett. 28 (2017) 75-82. doi: 10.1016/j.cclet.2016.06.022
25. [25]
  F. Meng, J. Wang, Q. Ping, et al., Nano Lett. 19 (2019) 1479-1487. doi: 10.1021/acs.nanolett.8b04017
26. [26]
  M.S. Mohamed, S. Veeranarayanan, T. Maekawa, D.S. Kumar, Adv. Drug Deliv. Rev. 138 (2019) 18-40. doi: 10.1016/j.addr.2018.10.007
27. [27]
  R. Mohammadpour, M.A. Dobrovolskaia, D.L. Cheney, et al., Adv. Drug Deliv. Rev. 144 (2019) 112-132. doi: 10.1016/j.addr.2019.07.006
28. [28]
  B. Liu, H. Zhang, Y. Ding, Chin. Chem. Lett. 29 (2018) 1725-1730. doi: 10.1016/j.cclet.2018.12.006
29. [29]
  L. Yu, R. Han, X. Sang, et al., ACS Nano 12 (2018) 9051-9059. doi: 10.1021/acsnano.8b02946
30. [30]
  Y.K. Peng, Y.J. Tseng, C.L. Liu, et al., Nanoscale 7 (2015) 2676-2687. doi: 10.1039/C4NR05825A
31. [31]
  Y. Piao, J. Kim, H.B. Na, et al., Nat. Mater. 7 (2008) 242-247. doi: 10.1038/nmat2118
32. [32]
  W. Zhou, L. Guo, Chem. Soc. Rev. 44 (2015) 6697-6707. doi: 10.1039/C5CS00033E
33. [33]
  Y. Cui, X. Li, K. Zeljic, et al., ACS Appl. Mater. Interfaces 11 (2019) 38190-38204. doi: 10.1021/acsami.9b15014
34. [34]
  Z. Wei, S. Luo, R. Xiao, et al., J. Hazard. Mater. 338 (2017) 472-481. doi: 10.1016/j.jhazmat.2017.06.001
35. [35]
  L.F.O. Maia, R.C. Hott, P.C.C. Ladeira, et al., Chemosphere 215 (2019) 422-431. doi: 10.1016/j.chemosphere.2018.10.072
36. [36]
  S.G. Chung, J.C. Ryu, M.K. Song, et al., J. Hazard. Mater. 267 (2014) 161-168. doi: 10.1016/j.jhazmat.2013.12.056
37. [37]
  J. Wang, X. Li, Q. Cheng, et al., Carbohydr. Polym. 229 (2020) 115470. doi: 10.1016/j.carbpol.2019.115470
38. [38]
  M. Xu, Y. Chen, G.B. Mao, et al., Mater. Express 9 (2019) 133-140. doi: 10.1166/mex.2019.1486
39. [39]
  X. Li, W. Chen, L. Ma, et al., Chemosphere 195 (2018) 336-343. doi: 10.1016/j.chemosphere.2017.12.080
40. [40]
  Y.K. Li, D. Li, K. Jian, et al., J. Biomed. Nanotechnol. 15 (2019) 85-99. doi: 10.1166/jbn.2019.2668
41. [41]
  C. Nayek, M.A. Al-Akhras, V. Narayanaswamy, et al., Mater. Express 9 (2019) 123-132. doi: 10.1166/mex.2019.1481
42. [42]
  M. Chen, B. Tang, D.E. Nikles, IEEE. T. Magn. 34 (1998) 1141-1143. doi: 10.1109/20.706418
43. [43]
  W.X. Chen, L.G. Yang, L.Y. Xu, et al., Biosci. Rep. 39 (2019) BSR20182062. doi: 10.1042/BSR20182062
44. [44]
  S. Zheng, X. Wang, Y.H. Weng, et al., Mol. Ther. Nucleic Acids 12 (2018) 805-816. doi: 10.1016/j.omtn.2018.08.003
1. [1]
  Zhilong Xie , Guohui Zhang , Ya Meng , Yefei Tong , Jian Deng , Honghui Li , Qingqing Ma , Shisong Han , Wenjun Ni . A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein. Chinese Chemical Letters, 2024, 35(11): 109584-. doi: 10.1016/j.cclet.2024.109584
2. [2]
  Yunjie Dang , Yanru Feng , Xiao Chen , Chaoxing He , Shujie Wei , Dingyang Liu , Jinlong Qi , Huaxing Zhang , Shaokun Yang , Zhiyun Niu , Bai Xiang . Development of a multi-level pH-responsive lipid nanoplatform for efficient co-delivery of siRNA and small-molecule drugs in tumor treatment. Chinese Chemical Letters, 2024, 35(12): 109660-. doi: 10.1016/j.cclet.2024.109660
3. [3]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
4. [4]
  Luyu Zhang , Zirong Dong , Shuai Yu , Guangyue Li , Weiwen Kong , Wenjuan Liu , Haisheng He , Yi Lu , Wei Wu , Jianping Qi . Ionic liquid-based in situ dynamically self-assembled cationic lipid nanocomplexes (CLNs) for enhanced intranasal siRNA delivery. Chinese Chemical Letters, 2024, 35(7): 109101-. doi: 10.1016/j.cclet.2023.109101
5. [5]
  Haijing Cui , Weihao Zhu , Chuning Yue , Ming Yang , Wenzhi Ren , Aiguo Wu . Recent progress of ultrasound-responsive titanium dioxide sonosensitizers in cancer treatment. Chinese Chemical Letters, 2024, 35(10): 109727-. doi: 10.1016/j.cclet.2024.109727
6. [6]
  Dexuan Xiao , Tianyu Chen , Tianxu Zhang , Sirong Shi , Mei Zhang , Xin Qin , Yunkun Liu , Longjiang Li , Yunfeng Lin . Transdermal treatment for malignant melanoma by aptamer-modified tetrahedral framework nucleic acid delivery of vemurafenib. Chinese Chemical Letters, 2024, 35(4): 108602-. doi: 10.1016/j.cclet.2023.108602
7. [7]
  Qiang Li , Jiangbo Fan , Hongkai Mu , Lin Chen , Yongzhen Yang , Shiping Yu . Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108947-. doi: 10.1016/j.cclet.2023.108947
8. [8]
  Yiran Tao , Chunlei Dai , Zhaoxiang Xie , Xinru You , Kaiwen Li , Jun Wu , Hai Huang . Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer. Chinese Chemical Letters, 2024, 35(8): 109170-. doi: 10.1016/j.cclet.2023.109170
9. [9]
  Wenjia Wang , Xingyue He , Xiaojie Wang , Tiantian Zhao , Osamu Muraoka , Genzoh Tanabe , Weijia Xie , Tianjiao Zhou , Lei Xing , Qingri Jin , Hulin Jiang . Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (Ⅳ) prodrug delivery and enhanced colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108656-. doi: 10.1016/j.cclet.2023.108656
10. [10]
  Qingqing SHEN , Xiangbowen DU , Kaicheng QIAN , Zhikang JIN , Zheng FANG , Tong WEI , Renhong LI . Self-supporting Cu/α-FeOOH/foam nickel composite catalyst for efficient hydrogen production by coupling methanol oxidation and water electrolysis. Chinese Journal of Inorganic Chemistry, 2024, 40(10): 1953-1964. doi: 10.11862/CJIC.20240028
11. [11]
  Jingyu Cai , Xiaoyu Miao , Yulai Zhao , Longqiang Xiao . Exploratory Teaching Experiment Design of FeOOH-RGO Aerogel for Photocatalytic Benzene to Phenol. University Chemistry, 2024, 39(4): 169-177. doi: 10.3866/PKU.DXHX202311028
12. [12]
  Tong Tong , Lezong Chen , Siying Wu , Zhong Cao , Yuanbin Song , Jun Wu . Establishment of a leucine-based poly(ester amide)s library with self-anticancer effect as nano-drug carrier for colorectal cancer treatment. Chinese Chemical Letters, 2024, 35(12): 109689-. doi: 10.1016/j.cclet.2024.109689
13. [13]
  Yang Liu , Yan Liu , Kaiyin Yang , Zhiruo Zhang , Wenbo Zhang , Bingyou Yang , Hua Li , Lixia Chen . A selective HK2 degrader suppresses SW480 cancer cell growth by degrading HK2. Chinese Chemical Letters, 2024, 35(8): 109264-. doi: 10.1016/j.cclet.2023.109264
14. [14]
  Kexin Yin , Jingren Yang , Yanwei Li , Qian Li , Xing Xu . Metal-free diatomaceous carbon-based catalyst for ultrafast and anti-interference Fenton-like oxidation. Chinese Chemical Letters, 2024, 35(12): 109847-. doi: 10.1016/j.cclet.2024.109847
15. [15]
  Huijiao Fu , Peiqin Liang , Qianwen Chen , Yan Wang , Guang Li , Xuzi Cai , Shengtao Wang , Kun Chen , Shengying Shi , Zhiqiang Yu , Xuefeng Wang . COX-2 blocking therapy in cisplatin chemosensitization of ovarian cancer: An allicin-based nanomedicine approach. Chinese Chemical Letters, 2024, 35(8): 109241-. doi: 10.1016/j.cclet.2023.109241
16. [16]
  Makhloufi Zoulikha , Zhongjian Chen , Jun Wu , Wei He . Approved delivery strategies for biopharmaceuticals. Chinese Chemical Letters, 2025, 36(2): 110225-. doi: 10.1016/j.cclet.2024.110225
17. [17]
  Zhigang Zeng , Changzhou Liao , Lei Yu . Molecules for COVID-19 treatment. Chinese Chemical Letters, 2024, 35(7): 109349-. doi: 10.1016/j.cclet.2023.109349
18. [18]
  Jun Xiong , Ke-Ke Chen , Neng-Bin Xie , Wei Chen , Wen-Xuan Shao , Tong-Tong Ji , Si-Yu Yu , Yu-Qi Feng , Bi-Feng Yuan . Demethylase-assisted site-specific detection of N¹-methyladenosine in RNA. Chinese Chemical Letters, 2024, 35(5): 108953-. doi: 10.1016/j.cclet.2023.108953
19. [19]
  Tian Feng , Yun-Ling Gao , Di Hu , Ke-Yu Yuan , Shu-Yi Gu , Yao-Hua Gu , Si-Yu Yu , Jun Xiong , Yu-Qi Feng , Jie Wang , Bi-Feng Yuan . Chronic sleep deprivation induces alterations in DNA and RNA modifications by liquid chromatography-mass spectrometry analysis. Chinese Chemical Letters, 2024, 35(8): 109259-. doi: 10.1016/j.cclet.2023.109259
20. [20]
  Yan Liu , Yang Wang , Jiayi Zhu , Xuxian Su , Xudong Lin , Liang Xu , Xiwen Xing . Employing pH-responsive RNA triplex to control CRISPR/Cas9-mediated gene manipulation in mammalian cells. Chinese Chemical Letters, 2024, 35(9): 109427-. doi: 10.1016/j.cclet.2023.109427

Get Citation

PDF

XML

Metrics

PDF Downloads(15)
Abstract views(1027)
HTML views(114)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142